Search results
Author(s):
L Nelson Hopkins
Added:
3 years ago
At least 795,000 people suffer a new or recurrent stroke each year in the US.1 Every 40 seconds, someone in the US has a stroke, and stroke is the third leading cause of death in the US.1 These numbers are likely to increase as the US population ages and as stroke awareness increases. In the past, ischaemic stroke has been managed with palliation and rehabilitation and with prevention of the…
View more
Author(s):
Henrik Bjursten
Added:
2 years ago
In this interview, Dr Henrik Bjursten (Lund University Hospital, Lund, SE) discusses the findings of a nationwide retrospective study evaluating the risk of stroke after TAVI procedures in Swedish patients.
Questions:
What was the rationale behind this study?
What was the design, patient cohort and endpoints?
How did you define stroke in this study?
What were the key findings?
What conclusions…
View more
Author(s):
Florian Hecker
,
Mani Arsalan
,
Thomas Walther
Added:
3 years ago
Transcatheter aortic valve replacement (TAVR) has become the default treatment option for high-risk patients with aortic stenosis (AS) and, based on heart team discussion, an alternative to surgical aortic valve replacement (SAVR) in intermediate-risk patients.
TAVR has led to a paradigm shift in the basic therapeutic principle to treat AS: calcifications, in some patients quite excessive, are…
View more
Author(s):
Rajesh Kharbanda
Added:
5 years ago
Prof Rajesh Kharbanda (The John Radcliffe Hospital, Oxford , UK) discusses stroke risk reduction in TAVI procedures.
Filmed on site at ACI 2019 by Radcliffe Cardiology
Questions:
1. What is the current incidence of stroke following TAVI?
2. What factors influence stroke risk in TAVI?
3. What can be done to mitigate stroke risk in these patients?
4. Should cerebral protection be used in…
View more
Author(s):
Maja Rojko
,
Natasa Cernic Suligoj
,
Metka Zorc
,
et al
Added:
11 months ago
Author(s):
Philippe Gabriel Steg
Added:
1 year ago
This broadcast series 'Where Do Potent P2Y12 Inhibitors Fit Into Current Practice?'will reappraise potent P2Y12 inhibitors, as evidence accumulates to support their broader use. At this juncture, there is still some uncertainty around patient selection, initiation and long-term management.
The fourth, and final, broadcast in this series, focused on Stroke Prevention.In this on-demand…
View more
Author(s):
Anne Alexandrov
Added:
1 month ago
AHA ISC 2024 — Dr Anne Alexandrov (University of Tennessee Health Science Center, US) joins us to summarise the key findings from the Zero Degree Head Positioning in Hyperacute Large Artery Ischaemic Stroke (ZODIAC) trial (NCT03728738).ZODIAC is a prospective randomized open blinded endpoint (PROBE) clinical trial investigating head positioning in hyperacute LVO ischemic stroke treatment. It aims…
View more
Author(s):
Tullio Palmerini
,
Carlo Savini
,
Marco Di Eusanio
Added:
3 years ago
Neurological dysfunction following coronary artery bypass graft (CABG) surgery can manifest as stroke, encephalopathy including delirium and post-operative cognitive dysfunction. Stroke is one of the most devastating complications after CABG surgery, entailing permanent disability and a 3–6 fold increased risk of death with a case-fatality rate up to 20 %.1,2 It is also associated with…
View more
Author(s):
Samir R Kapadia
Added:
1 year ago
TCT 22 - In this short interview, Dr Samir Kapadia (Cleveland Clinic, OH, US) outlines the findings of the PROTECTED-TAVR trial, which aimed to demonstrate the performance of Boston Scientific's Sentinel® Cerebral Protection System in transcatheter aortic valve replacement.
In this study, 3000 patients were randomized to receive either TAVR with the Sentinel system or TAVR without intervention…
View more
Stroke Prophylaxis by Percutaneous Closure of Patent Foramen Ovale and Left Atrial Appendage
Author(s):
Antonio L Bartorelli
,
Claudio Tondo
Added:
3 years ago
Article